Earl Conner C, Jauregui Alexa M, Lin Guang, Hor Kan N, Markham Larry W, Soslow Jonathan H, Goergen Craig J
Weldon School of Biomedical Engineering, Purdue University, West Lafayette, IN.
Indiana University School of Medicine, Indianapolis, IN.
medRxiv. 2023 Nov 8:2023.11.07.23298238. doi: 10.1101/2023.11.07.23298238.
Cardiomyopathy (CMP) is the leading cause of death in Duchenne muscular dystrophy (DMD). Characterization of disease trajectory can be challenging, especially in the early stage of CMP where onset and clinical progression may vary. Traditional metrics from cardiovascular magnetic resonance (CMR) imaging such as LVEF (left ventricular ejection fraction) and LGE (late gadolinium enhancement) are often insufficient for assessing disease trajectory. We hypothesized that strain patterns from a novel 4D (3D+time) CMR regional strain analysis method can be used to predict the rate of DMD CMP progression.
We compiled 115 short-axis cine CMR image stacks for n=40 pediatric DMD patients (13.6±4.2 years) imaged yearly for 3 consecutive visits and computed regional strain metrics using custom-built feature tracking software. We measured regional strain parameters by determining the relative change in the localized 4D endocardial surface mesh using end diastole as the initial reference frame.
We first separated patients into two cohorts based on their initial CMR: LVEF≥55% (n=28, normal cohort) and LVEF<55% (n=12, abnormal cohort). Using LVEF decrease measured two years following the initial scan, we further subclassified these cohorts into slow (ΔLVEF%≤5) or fast (ΔLVEF%>5) progression groups for both the normal cohort (n=12, slow; n=15, fast) and the abnormal cohort (n=8, slow; n=4, fast). There was no statistical difference between the slow and fast progression groups in standard biomarkers such as LVEF, age, or LGE status. However, basal circumferential strain (E) late diastolic strain rate and basal surface area strain (E) late diastolic strain rate magnitude were significantly decreased in fast progressors in both normal and abnormal cohorts (<0.01, =0.04 and <0.01, =0.02, respectively). Peak E and E magnitudes were also decreased in fast progressors, though these only reached statistical significance in the normal cohort (<0.01, =0.24 and <0.01, =0.18, respectively).
Regional strain metrics from 4D CMR can be used to differentiate between slow or fast CMP progression in a longitudinal DMD cohort. These results demonstrate that 4D CMR strain is useful for early identification of CMP progression in patients with DMD.
Cardiomyopathy is the number one cause of death in Duchenne muscular dystrophy, but the onset and progression of the disease are variable and heterogeneous. In this study, we used a novel 4D cardiovascular magnetic resonance regional strain analysis method to evaluate 40 pediatric Duchenne patients over three consecutive annual visits. From our analysis, we found that peak systolic strain and late diastolic strain rate were early indicators of cardiomyopathy progression. This method offers promise for early detection and monitoring, potentially improving patient outcomes through timely intervention and management.
心肌病(CMP)是杜氏肌营养不良症(DMD)的主要死因。疾病轨迹的特征描述可能具有挑战性,尤其是在CMP的早期阶段,其发病和临床进展可能有所不同。心血管磁共振(CMR)成像的传统指标,如左心室射血分数(LVEF)和延迟钆增强(LGE),通常不足以评估疾病轨迹。我们假设,一种新型的4D(3D+时间)CMR区域应变分析方法得出的应变模式可用于预测DMD-CMP的进展速度。
我们为40名儿科DMD患者(13.6±4.2岁)编制了115个短轴电影CMR图像堆栈,这些患者每年进行一次成像,连续进行3次随访,并使用定制的特征跟踪软件计算区域应变指标。我们通过以舒张末期为初始参考帧,确定局部4D心内膜表面网格的相对变化来测量区域应变参数。
我们首先根据患者的初始CMR将其分为两个队列:LVEF≥55%(n=28,正常队列)和LVEF<55%(n=12,异常队列)。使用初次扫描后两年测量的LVEF下降情况,我们将这些队列进一步细分为正常队列(n=12,进展缓慢;n=15,进展快速)和异常队列(n=8,进展缓慢;n=4,进展快速)中的缓慢(ΔLVEF%≤5)或快速(ΔLVEF%>5)进展组。在LVEF、年龄或LGE状态等标准生物标志物方面,缓慢进展组和快速进展组之间没有统计学差异。然而,正常队列和异常队列中快速进展者的基底圆周应变(E)舒张末期应变率和基底表面积应变(E)舒张末期应变率幅度均显著降低(分别为<0.01,=0.04和<0.01,=0.02)。快速进展者的E和E幅度峰值也有所降低,尽管这些仅在正常队列中达到统计学意义(分别为<0.01,=0.24和<0.01,=0.18)。
4D CMR的区域应变指标可用于区分纵向DMD队列中CMP的缓慢或快速进展。这些结果表明,4D CMR应变有助于早期识别DMD患者的CMP进展。
心肌病是杜氏肌营养不良症的首要死因,但该疾病的发病和进展是可变且异质的。在本研究中,我们使用一种新型的4D心血管磁共振区域应变分析方法,对40名儿科杜氏患者进行了连续三年的年度随访评估。通过我们的分析,我们发现收缩期峰值应变和舒张末期应变率是心肌病进展的早期指标。这种方法为早期检测和监测提供了希望,有可能通过及时干预和管理改善患者预后。